Literature DB >> 27701062

Therapeutic strategy for efficient reduction of serum uric acid levels with allopurinol versus benzbromarone in hyperuricemic patients with essential hypertension - A randomized crossover study (terao study).

Sunao Kojima1, Shinobu Kojima2, Atsuko Hifumi2, Hirofumi Soejima3, Hisao Ogawa4.   

Abstract

Entities:  

Keywords:  Hyperuricemia; UACR; Uric acid; Xanthine oxidase inhibitor

Mesh：

Substances：

Year:  2016        PMID： 27701062     DOI： 10.1016/j.ijcard.2016.09.073

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

1.  Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials.

Authors:  Tunlanut Sapankaew; Kunlawat Thadanipon; Narisa Ruenroengbun; Kamolpat Chaiyakittisopon; Atiporn Ingsathit; Pawin Numthavaj; Nathorn Chaiyakunapruk; Gareth McKay; John Attia; Ammarin Thakkinstian
Journal:  BMC Nephrol       Date:  2022-06-23       Impact factor: 2.585

2.  Enhancement of oral bioavailability and anti-hyperuricemic activity of aloe emodin via novel Soluplus®-glycyrrhizic acid mixed micelle system.

Authors:  Feng Shi; Lin Chen; Yaping Wang; Jing Liu; Michael Adu-Frimpong; Hao Ji; Elmurat Toreniyazov; Qilong Wang; Jiangnan Yu; Ximing Xu
Journal:  Drug Deliv Transl Res       Date:  2021-04-15       Impact factor: 4.617

Review 3.  Physiology of Hyperuricemia and Urate-Lowering Treatments.

Authors:  Caroline L Benn; Pinky Dua; Rachel Gurrell; Peter Loudon; Andrew Pike; R Ian Storer; Ciara Vangjeli
Journal:  Front Med (Lausanne)       Date:  2018-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.